Same Drug Class

Methotrexate vs Tofacitinib

Methotrexate vs Tofacitinib: Overview

This comparison examines the pharmacological differences between Methotrexate and Tofacitinib.

Mechanism of Action

Methotrexate: Dihydrofolate reductase inhibitor.

Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

Pharmacokinetics

Half-life: Methotrexate — 3-10 hours; Tofacitinib — 3.2 hours.

Chemical Properties

Molecular Formula: Methotrexate — C20H22N8O5; Tofacitinib — C16H20N6O.

Molecular Weight: Methotrexate — 454.4400 g/mol; Tofacitinib — 312.3700 g/mol.

Type: Methotrexate — Small molecule; Tofacitinib — Small molecule.